Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients
Clinical trial NCT02675803 · COMPLETED
Trial details
- NCT number
- NCT02675803
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-20
- Primary completion
- 2018-01-22
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.